Summit Asset Management, LLC Abb Vie Inc. Transaction History

Summit Asset Management, LLC

$841 Million
Q1 2024

A detailed history of Summit Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Asset Management, LLC holds 4,909 shares of ABBV stock, worth $821,030. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,909

Previous 4,907 0.04%

Holding current value

$821,030

Previous $760,000 17.5%

% of portfolio

0.11%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $319 - $364	2 Added 0.04%	4,909 $893,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $72,652 - $81,824	528 Added 12.06%	4,907 $760,000
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $133 - $154	1 Added 0.02%	4,379 $652,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $6,758 - $8,409	-51 Reduced 1.15%	4,378 $589,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $14,750 - $16,987	102 Added 2.36%	4,429 $705,000

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $276 - $331	2 Added 0.05%	4,327 $699,000
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $134 - $153	1 Added 0.02%	4,325 $581,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $18,578 - $23,619	-135 Reduced 3.03%	4,324 $662,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $34,182 - $42,411	259 Added 6.17%	4,459 $723,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $36,203 - $45,808	337 Added 8.72%	4,200 $569,000
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $40,644 - $46,137	-382 Reduced 9.0%	3,863 $417,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $41,242 - $45,946	392 Added 10.17%	4,245 $478,000
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $50,127 - $55,183	-490 Reduced 11.28%	3,853 $417,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $40,969 - $55,313	509 Added 13.28%	4,343 $465,000
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $52,319 - $61,405	609 Added 18.88%	3,834 $336,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $236,618 - $316,630	3,225 New	3,225 $317,000
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $162,733 - $246,724	-2,523 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $181,983 - $227,700	2,523 New	2,523 $223,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $187,758 - $220,982	-2,434 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $1,012 - $1,248	13 Added 0.54%	2,434 $224,000
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $1,066 - $1,186	12 Added 0.5%	2,421 $229,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $987 - $1,168	11 Added 0.46%	2,409 $223,000
Q1 2018 May 07, 2018	BUY	$92.01 - $123.21 $644 - $862	7 Added 0.29%	2,398 $227,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $13,344 - $14,633	-149 Reduced 5.87%	2,391 $231,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $177,419 - $226,618	2,540	2,540 $226,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Asset Management, LLC with notifications on news.

Account

Summit Asset Management, LLC Abb Vie Inc. Transaction History